2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Morning Seminar

[MoS12] Morning Seminar 12　Tumor-Agnostic Approach for NTRK Fusion Gene-Positive Solid Tumors

Sat. Feb 19, 2022 7:20 AM - 8:10 AM Room 3 (Annex 2, 1F, Kyoto International Conference Center)

Chair：Noboru Yamamoto（National Cancer Center Hospital, Department of Experimental Therapeutics）

Sponsored by CHUGAI PHARMACEUTICAL CO., LTD.

[MoS12-1] Targeting NTRK-fusions as the Oncogenic Driver of Many Cancer Types: Putting Tumor Agnostic Approach into Practice

○George D. Demetri (Dana-Farber Cancer Institute and Ludwing Center at Harvard Medical School, United States)